HCN News Team – Page 16 – Highly Capitalized

Monday, March 23, 2026 We Follow The Money.

About HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Indiana Residents Voice Strong Support for Medical and Recreational Cannabis Legalization

HCN News Team2026-01-14T07:35:16-08:00January 14th, 2026|Survey|

INDIANAPOLIS – A recent survey of Hoosier voters indicates broad ...

Bipartisan Bill Aims to Push Back Hemp Ban for Two Years

HCN News Team2026-01-14T06:06:43-08:00January 14th, 2026|Hemp|

WASHINGTON – A group of lawmakers from both parties filed ...

U.S. Legal Cannabis Sales Hit $2.3B in December, Lifting 2025 Total to $27B

HCN News Team2026-01-14T02:23:22-08:00January 14th, 2026|Market Research|

LOS ANGELES – Legal Cannabis sales across the United States ...

California DCC Grants $1.8M to UC Berkeley and Glass House Brands for Cannabis Yield Study

HCN News Team2026-01-13T09:15:41-08:00January 13th, 2026|Research|

LONG BEACH – State regulators have awarded $1.8 million to ...

MindMed Rebrands as Definium Therapeutics, Targets 2026 Trials for LSD-Based Treatments

HCN News Team2026-01-13T07:24:53-08:00January 13th, 2026|Psychedelics|

NEW YORK – Mind Medicine (MindMed) Inc., a developer of ...

Sunderstorm Welcomes Lime to Its Family of Brands

HCN News Team2026-01-12T09:18:15-08:00January 12th, 2026|M&As|

LOS ANGELES – Sunderstorm, the California-based Cannabis company behind the ...

Curaleaf Observes Delaware Base to Tighten U.S. Footprint

HCN News Team2026-01-12T04:31:09-08:00January 12th, 2026|Business, MSOs|

DOVER – Curaleaf Holdings Inc. has filed for shareholder approval ...

Tilray Brands Reports Q2 Fiscal 2026 Financial Results

HCN News Team2026-01-13T05:45:15-08:00January 12th, 2026|Report|

NEW YORK – Tilray Brands Inc. posted net revenue of ...

Helus Pharma Rings Nasdaq Bell Post-Cybin Rebrand

HCN News Team2026-01-09T17:41:31-08:00January 9th, 2026|Psychedelics|

TORONTO – Helus Pharma Inc., rebranded from Cybin Inc., opened ...

Who Will Decide Cannabis Legalization? The Math Will.

HCN News Team2026-01-09T13:18:44-08:00January 8th, 2026|Business, Insights|

LOS ANGELES -For decades, Cannabis reform in the United States ...

Previous 151617 Next

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.